Atlas Trials

Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.

Clinical trial NCT01130688 · TERMINATED

Trial details

NCT number
NCT01130688
Sponsor
University of Massachusetts, Worcester
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Myelogenous Leukemia
Start date
2010-01-01
Primary completion
2012-10-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.